Index · Open funds
Seed venture funds investing in Biotech, Massachusetts
13 venture funds from 8 firms are raising or writing first checks for Seed-stage companies in Biotech, based in or investing in Massachusetts. Each fund qualifies by its stated focus or by deals it announced in the last 24 months.
13 funds
- 2048 Ventures III, LP$547K to $1.03M (estimated from fund size)Open, writing first checks
- Agent Capital Fund III LP$533K to $1.67M (estimated from fund size)Open, writing first checks
- BEV Follow-On Fund I, LLC$1M to $1.88M (estimated from fund size)Open, writing first checks
- E14 Fund 3 Limited Partnership$785K to $1.47M (estimated from fund size)Open, writing first checks
- RA Capital Planetary Health Fund, L.P.$1.22M to $2.04M (estimated from fund size)Open, writing first checks
- RA Capital Planetary Health International Fund, L.P.$303K to $1.04M (estimated from fund size)Open, writing first checks
- Springhood Child Health Ventures Fund I, L.P.$17K to $333K (estimated from fund size)Open, writing first checks
- T.Rx Capital Fund I, LP$772K to $2.92M (estimated from fund size)Open, writing first checks
T.Rx Capital, MA
- E14 Fund 4 Limited Partnership$667K to $1.25M (estimated from fund size)Raising
- Third Rock Ventures VII, L.P.$7.5M to $12.5M (estimated from fund size)Raising
- 2048 Ventures II, LP$442K to $828K (estimated from fund size)Late investment period
- Material Impact Fund III, L.P.$2.08M to $4.3M (estimated from fund size)Late investment period
- Third Rock Ventures VI, L.P.$11.05M to $18.52M (estimated from fund size)Late investment period